Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
3.030
+0.150 (5.21%)
At close: Jun 6, 2025, 4:00 PM
3.390
+0.360 (11.88%)
After-hours: Jun 6, 2025, 7:59 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $384.37 million as of June 6, 2025. Its market cap has increased by 4.67% in one year.
Market Cap
384.37M
Enterprise Value
317.03M
1-Year Change
4.67%
Ranking
Category
Stock Price
$3.03
Market Cap Chart
Since January 5, 2017, Organogenesis Holdings's market cap has increased from $376.60M to $384.37M, an increase of 2.06%. That is a compound annual growth rate of 0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 384.40M | -9.38% |
| Dec 31, 2024 | 424.20M | -21.44% |
| Dec 29, 2023 | 540.00M | 53.32% |
| Dec 30, 2022 | 352.20M | -70.37% |
| Dec 31, 2021 | 1.19B | 46.45% |
| Dec 31, 2020 | 811.60M | 78.10% |
| Dec 31, 2019 | 455.70M | 30.13% |
| Dec 31, 2018 | 350.20M | -8.90% |
| Dec 29, 2017 | 384.40M | 2.07% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |